Coagulation in Cirrhosis.

08:00 EDT 12th April 2019 | BioPortfolio

Summary of "Coagulation in Cirrhosis."

No Summary Available


Journal Details

This article was published in the following journal.

Name: Gastroenterology
ISSN: 1528-0012


DeepDyve research library

PubMed Articles [982 Associated PubMed Articles listed on BioPortfolio]

Charges for Alcoholic Cirrhosis Exceed All Other Etiologies of Cirrhosis Combined: A National and State Inpatient Survey Analysis.

Inpatient charges for patients with cirrhosis are substantial. We aimed to examine trends in inpatient charges among patients with cirrhosis to determine the drivers of healthcare expenditures. We hyp...

The regulatory role of coagulation factors in vascular function.

The coagulation takes place in the hemostasis system and is a is hallmarked by a complex interplay of reactions between coagulation proteins. In the presence of a vascular breach, the conversion of pr...

Infections in Cirrhosis.

Patients with cirrhosis are at high risk of developing serious infections. Bacterial infections remain the most common cause of morbidity and mortality in these patients. This review is focused on the...

Anticoagulation in Cirrhosis and Portal Vein Thrombosis Is Safe and Improves Prognosis in Advanced Cirrhosis.

The role of portal vein thrombosis (PVT) in the natural history of cirrhosis is controversial.

Activation of blood coagulation after aneurysmal subarachnoid haemorrhage: a prospective observational trial by rotational thromboelastometry (ROTEM®).

Aneurysmal subarachnoid haemorrhage (aSAH) is reported to actuate blood coagulation. Rotational thromboelastometry (ROTEM®) is a dynamic haemostatic test that can differentiate various coagulation ab...

Clinical Trials [1232 Associated Clinical Trials listed on BioPortfolio]


Patients with cirrhosis of viral etiology (HCV/HBV); Patients with cirrhosis of any other etiology (alcohol, idiopatic, autoimmune). Planned Number of cirrhotic subjects 200 patients Inclu...

Rôle of the Soluble Endothelial Protein C Receptor in Cirrhosis-associated Hypercoagulability State (EXERCISE)

Cirrhosis is a condition in which the liver does not function properly due to long-term damage. This damage is characterized by the replacement of normal liver tissue by scar tissue. ...

Microwave Ablation and Partial Splenic Embolization in the Management of Hypersplenism

The aim of this study is to compare microwave thermal coagulation and partial splenic embolization in the management of hypersplenism in patients with cirrhosis. This study will be conduc...

Risk Factors and Outcomes of Acute Venous Thromboembolism in Cirrhotic

patient with liver cirrhosis was supposed to have autoanticoagulation which approved to be wrong, with absence of conventional method to detect all abnormalities in coagulation state. Thro...

Thrombin Generation Test in Patient With Liver Cirrhosis

Cirrhotic patients are patients with high morbidity and mortality, it is very important for determining the prognosis of these patients. The importance increases when these patients waitin...

Medical and Biotech [MESH] Definitions

Experimentally induced chronic injuries to the parenchymal cells in the liver to achieve a model for LIVER CIRRHOSIS.

The coagulation of tissue by an intense beam of light, including laser (LASER COAGULATION). In the eye it is used in the treatment of retinal detachments, retinal holes, aneurysms, hemorrhages, and malignant and benign neoplasms. (Dictionary of Visual Science, 3d ed)

FIBROSIS of the hepatic parenchyma due to obstruction of BILE flow (CHOLESTASIS) in the intrahepatic or extrahepatic bile ducts (BILE DUCTS, INTRAHEPATIC; BILE DUCTS, EXTRAHEPATIC). Primary biliary cirrhosis involves the destruction of small intra-hepatic bile ducts and bile secretion. Secondary biliary cirrhosis is produced by prolonged obstruction of large intrahepatic or extrahepatic bile ducts from a variety of causes.

Substances, usually endogenous, that act as inhibitors of blood coagulation. They may affect one or multiple enzymes throughout the process. As a group, they also inhibit enzymes involved in processes other than blood coagulation, such as those from the complement system, fibrinolytic enzyme system, blood cells, and bacteria.

Hemorrhagic and thrombotic disorders that occur as a consequence of abnormalities in blood coagulation due to a variety of factors such as COAGULATION PROTEIN DISORDERS; BLOOD PLATELET DISORDERS; BLOOD PROTEIN DISORDERS or nutritional conditions.

Quick Search


DeepDyve research library

Searches Linking to this Article